CAS: 61903-11-5; 1-(1,4-Diazepan-1-yl)Ethanone

该化合物是一种化学化合物,其特点是其管子环结构,即六人组成的饱和异丙环,含有两个氮原子;在同气管结构的1位置上存在乙酰组,有助于其再活性并潜在地应用于各种化学合成;该化合物一般无色可粉黄黄色液体或固体,取决于其纯度和具体条件;它溶于极地有机溶剂,可提高其在有机合成和制药应用中的效用;1-乙酰甲型甲型六氯环己烷可能展示生物活动,使其对药用化学有兴趣,以开发新的治疗剂;与许多含氮的异丙型乙型六氯环己烷一样,它可能参与氢联结和其他分子间相互作用,影响其物理和化学特性;在处理和储存时,应参考安全数据,如任何化学物质,以确保采取适当的预防措施.

结构式图片

相似化合物

1201633-56-8 1389313-58-9 1269053-62-4

欧盟法规

ECHA物质C&L通报

上下游产品

1,4-Diazacycloheptane acetic anhydride4-(4-N-acetyl-[1,4]diazepan-1-yl)-3-chloro-benzonitrile 1-ethyl-1,4-homopiperazine 5-[5-(4-acetyl[1,4]diazepan-1-yl)-2-methylpentanoylamino]-3-(4-methoxyphenyl)pyrazole-1-carboxylic acid tert-butyl ester 14H19N3O3C14H19N3O3

合成工艺路线路线简述

  • 合成目标产物 N-Acetylhomopiperazine 主要起始原料 Homopiperazine And Acetic Anhydride
  • (文献来源)合成步骤主要原料 Homopiperazine 和 Acetic Anhydride
1-(3-Benzyl[1,4]Diazepan-1-yl)Ethanone置于palladium On Carbon,氢气体系中,用 乙醇 作为反应溶剂,以89%的收率获得产物1-乙酰基-1H-1,4-二氮杂庚烷
参考文献:两种有效的认知增强剂sunifiram和sapunifiram的新类似物的设计,合成和促智活性
标题:两种有效的认知增强剂sunifiram和sapunifiram的新类似物的设计,合成和促智活性
摘要:合成了一系列与dm235(sunifiram)和mn19(sapunifiram)结构相关的酰胺和磺酰胺,它们是通过环的扩张或收缩,或通过环外酰胺功能的反转而衍生的,并测试了其在小鼠被动中的认知增强活性-回避测试.一些化合物显示出非常好的抗记忆和认知活性,具有比吡乙酰胺更高的效力,并且具有与母体化合物相似的效力.
DOI:10.1016/j.Bmc.2009.08.055

海关参考信息

专利信息


专利号:US-6906046-B2
优先权日:2000-12-22
标题 :Pharmaceutical uses and synthesis of benzobicyclooctanes
发明人:JACKSON RANDY W; DARWISH IHAB; BAUGHMAN TED A; HOWBERT J JEFFRY
权利人:CELLTECH R & D INC
摘要:Benzobicyclooctane compounds, their use in inhibiting cellular events involving TNF-α and IL-8, and in the treatment of inflammation events in general; a combinatorial library of diverse bicyclooctanes and process for their synthesis as a library and as individual compounds.

专利号:US-2009264648-A1
优先权日:2008-01-14
标题:Synthesis of pyrazoles
发明人:CHEW WARREN; WANG ZHENG; CHEAL GLORIA; BERTRAND MARTIAL; POTOSKI JOHN; MIRMEHRABI MAHMOUD; NENCINI ARIANNA; ZANALETTI RICCARDO
权利人:WYETH CORP; SIENA BIOTECH SPA
摘要:The present invention provides compounds and compositions, methods of making them, and methods of using them to modulate α7 nicotinic acetylcholine receptors and/or to treat any of a variety of disorders, diseases, and conditions. Provided compounds can affect, among other things, neurological, psychiatric and/or inflammatory system.

专利号:US-10995078-B2
优先权日:2013-03-13
标 题:Compounds and compositions for inhibition of FASN
发明人:BAIR KENNETH W; LANCIA JR DAVID R; LI HONGBIN; LOCH JAMES; LU WEI; MARTIN MATTHEW W; MILLAN DAVID S; SCHILLER SHAWN E R; TEBBE MARK J
权利人:FORMA THERAPEUTICS INC
摘要:The present invention relates to compounds and composition for inhibition of FASN, their synthesis, applications, and antidotes. An illustrative compound of the invention is shown below:

专利号:US-6407103-B2
优先权日:1998-04-21
标 题:Indeno [1,2-c] pyrazol-4-ones and their uses
发明人:NUGIEL DAVID A; CARINI DAVID J; DI MEO SUSAN V; YUE EDDY W
权利人:BRISTOL MYERS SQUIBB PHARMA CO
摘要:The present invention relates to the synthesis of a new class of indeno[1,2-c]pyrazol-4-ones of formula (I):that are potent inhibitors of the class of enzymes known as cyclin dependent kinases, which relate to the catalytic subunits cdk1-9 and their regulatory subunits know as cyclins A-H.This invention also provides a novel method of treating cancer or other proliferative diseases by administering a therapeutically effective amount of one of these compounds or a pharmaceutically acceptable salt form thereof. Alternatively, one can treat cancer or other proliferative diseases by administering a therapeutically effective combination of one of the compounds of the present invention and one or more other known anti-cancer or anti-proliferative agents.

专利号:WO-2009091832-A1
优先权日:2008-01-14
标题 :Synthesis of pyrazoles

专利号:US-9676721-B2
优先权日:2010-09-03
标题 :Compounds and compositions for the inhibition of NAMPT
发明人:BAIR KENNETH W; BUCKMELTER ALEXANDRE J; HAN BINGSONG; LIN JIAN; REYNOLDS DOMINIC J; SMITH CHASE C; WANG ZHONGGUO; ZHENG XIAOZHANG
权利人:BAIR KENNETH W; BUCKMELTER ALEXANDRE J; HAN BINGSONG; LIN JIAN; REYNOLDS DOMINIC J; SMITH CHASE C; WANG ZHONGGUO; ZHENG XIAOZHANG; FORMA TM LLC
摘要:The present invention relates to compounds and compositions for the inhibition of NAMPT, their synthesis, applications and antidotes. An illustrative compound of the invention is shown below.
南京哈柏医药科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.habotech.com
电话: 025-85760892 13376090521👤
📞南京哈柏医药科技有限公司 ⚠️参考联系方式

销售电话:025-85760892 13376090521
邮箱:sales@habotech.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


参考文献:10.1016/j.str.2024.01.005
摘要:Bradshaw WJ, Kennedy EC, Moreira T, Smith LA, Chalk R, Katis VL, Benesch JLP, Brennan PE, Murphy EJ, Gileadi O. Regulation of inositol 5-phosphatase activity by the C2 domain of SHIP1 and SHIP2. Structure. 2024 Apr 04;32(4):453–466.e6.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知